LAUREEN DEBUONO

Insider Reports History

Signature
Svai Sanford. Attorney-in-Fact for Laureen DeBuono
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LAUREEN DEBUONO:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rani Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 135,896 16 Dec 2024 Direct
Pulse Biosciences, Inc. Director Stock Option (right to buy) 32,500 04 Oct 2021 Direct

Insider Reports Filed by LAUREEN DEBUONO

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RANI Rani Therapeutics Holdings, Inc. 16 Dec 2024 4 $0 4 Director 17 Dec 2024, 17:00
RANI Rani Therapeutics Holdings, Inc. 29 May 2024 1 $0 4 Director 30 May 2024, 16:10
RANI Rani Therapeutics Holdings, Inc. 16 Dec 2023 4 $0 4 Director 19 Dec 2023, 16:05
RANI Rani Therapeutics Holdings, Inc. 25 May 2023 1 $0 4 Director 30 May 2023, 20:06
RANI Rani Therapeutics Holdings, Inc. 25 May 2022 1 $0 4 Director 27 May 2022, 08:30
PLSE Pulse Biosciences, Inc. 04 Oct 2021 1 $0 4 Director 06 Oct 2021, 16:11
PLSE Pulse Biosciences, Inc. 04 Oct 2021 0 $0 3 Director 06 Oct 2021, 16:10
RANI Rani Therapeutics Holdings, Inc. 29 Jul 2021 0 $0 3/A Director 02 Aug 2021, 19:48